Nr5a2 Antibody

What is NR5A2/LRH-1 and why is it significant in research?

NR5A2, also known as Liver Receptor Homolog-1 (LRH-1), is a nuclear receptor protein with an approximate molecular weight of 55 kDa that functions as a key metabolic sensor. This transcription factor regulates genes involved in multiple critical processes including bile acid synthesis, cholesterol homeostasis, and triglyceride synthesis. NR5A2 plays an essential role as a transcriptional regulator of lipid metabolism alongside oxysterol receptors NR1H3/LXR-alpha and NR1H2/LXR-beta . The protein is critically important in development, as evidenced by the non-viability of complete NR5A2 knockout mice . Research interest in NR5A2 stems from its diverse functions across multiple tissues, including anti-inflammatory roles in the liver, regulation of pancreatic function, neural development control, and involvement in steroidogenesis pathways.

What are the key applications for which NR5A2 antibodies have been validated?

NR5A2 antibodies have been validated for several research applications, with Western blotting (WB) being the most commonly confirmed application across commercial antibodies . Immunohistochemistry (IHC) and immunocytochemistry (ICC) applications have been documented in published research, particularly in studies examining neural stem cell differentiation and inflammatory processes in pancreatic tissue . Chromatin immunoprecipitation (ChIP) applications have been validated in studies examining NR5A2 binding to gene promoters, particularly in the context of inflammatory gene regulation . Immunoprecipitation (IP) has also been used to study protein-protein interactions between NR5A2 and other regulatory factors such as Nr0b2 .

How should researchers select between different NR5A2 antibody epitopes?

Selection of NR5A2 antibodies should be based on the specific research question and target isoform. Available commercial antibodies target different epitope regions, including:

Researchers should consider:

• The protein domain structure of NR5A2 and whether functional domains are being targeted

• Conservation of epitope sequences across species if working with non-human models

• Potential post-translational modifications that might affect antibody binding

• Isoform specificity, as multiple isoforms exist across species (4 human, 3 mouse, and 3 rat isoforms have been documented)

What controls are essential when using NR5A2 antibodies in research applications?

Proper experimental design with NR5A2 antibodies requires rigorous controls:

Positive Controls:

• Known NR5A2-expressing tissues (liver, intestine, pancreas, ovary, preadipocytes)

• Recombinant NR5A2 protein for Western blot calibration

• Cell lines with confirmed NR5A2 expression (such as 266-6 acinar cells)

Negative Controls:

• NR5A2 knockout or knockdown samples (such as the LO2-NR5A2 1in9397 or AML12-Nr5a2 6in327 cell lines)

• Pre-immune serum or isotype-matched control antibodies

• Tissues known not to express NR5A2

Technical Controls:

• Loading controls for Western blots (housekeeping proteins)

• Secondary antibody-only controls to assess non-specific binding

• Peptide competition assays to confirm specificity

How can researchers optimize ChIP-qPCR protocols for studying NR5A2 binding to gene promoters?

Chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR) has been successfully applied to study NR5A2 binding to various gene promoters . Optimization includes:

• Crosslinking Optimization: Standard 1% formaldehyde for 10 minutes at room temperature works for most nuclear receptors, but titration may be needed for optimal NR5A2 detection

• Sonication Parameters: Aim for chromatin fragments of 200-500bp, with sonication conditions optimized for each tissue or cell type

• Antibody Selection: Use ChIP-validated antibodies with confirmed specificity; research indicates successful ChIP applications with antibodies targeting the DNA-binding domain

• Primer Design for Target Genes: Design primers for known NR5A2 binding sites including:

  • Inflammatory gene promoters (c-Fos, Fosl1)

  • Metabolic gene promoters (CYP7A)

  • Nr0b2 promoter regions

• Data Analysis: Calculate enrichment as percent of input or fold enrichment over IgG control; published data shows significant enrichment at specific promoters in Nr5a2+/− mice compared to wild-type

What are the key considerations for using NR5A2 antibodies in neural stem cell research?

NR5A2 plays crucial roles in neural stem cell (NSC) fate decisions, and antibody-based detection requires specific considerations:

• Sample Preparation: For NSC cultures, paraformaldehyde fixation (4%) for 15-20 minutes has been shown to preserve epitopes while maintaining cellular morphology

• Co-staining Applications: Researchers should consider co-staining with markers including:

  • NSC markers (Nestin, Sox2)

  • Proliferation markers (BrdU, pH3, CyclinD1)

  • Differentiation markers (βIII-Tubulin for neurons, GFAP for astrocytes)

• Specificity Validation: Confirm antibody specificity using NR5A2 knockdown samples; published research has utilized lentiviral-mediated shRNA knockdown of NR5A2

• Quantification Methods: For accurate assessment of NR5A2's effects on differentiation, researchers should quantify:

  • Percentage of marker-positive cells

  • Intensity of staining

  • Morphological characteristics

Research findings demonstrate that NR5A2 overexpression increases neuronal differentiation (~2.5-fold increase in βIII-Tubulin+ neurons), while knockdown enhances proliferation and astrogliogenesis .

How can researchers study the relationship between NR5A2 and inflammatory pathways?

NR5A2 has been implicated in inflammatory regulation, particularly in pancreatic and liver tissues. Research approaches include:

• Haploinsufficiency Models: Nr5a2+/− mice display a pre-inflammatory phenotype that mimics early pancreatitis-induced inflammation

• Transcriptional Profiling: RNA-seq analysis can identify inflammatory genes regulated by NR5A2, including AP-1 family members (c-Fos, Fosl1)

• Protein-Protein Interaction Studies: Co-immunoprecipitation with NR5A2 antibodies can identify interactions with co-repressors (like Nr0b2) that mediate inflammatory suppression

• ChIP-seq Approaches: Genome-wide binding analysis has revealed that NR5A2 undergoes a "transcriptional switch" in haploinsufficient states, relocating from differentiation-specific genes to inflammatory gene promoters

• Rescue Experiments: The pre-inflammatory phenotype in Nr5a2+/− mice can be rescued by pancreatic deletion of c-Jun, confirming the mechanistic relationship between NR5A2 and AP-1 transcription factors

What experimental approaches are recommended for studying the role of NR5A2 in cell death pathways such as pyroptosis?

Recent research has identified a connection between NR5A2 deficiency and pyroptosis, particularly in liver cells . Recommended approaches include:

• Genetic Manipulation Models:

  • Cell lines with NR5A2 knockout or knockdown (e.g., LO2-NR5A2 1in9397)

  • Hepatocyte-specific Nr5a2 knockout mice

  • Consideration of haploid vs. complete knockout models, as complete knockout of NR5A2 appears to be lethal in some cell types

• Pyroptosis Detection Methods:

  • LDH release assays to measure cell membrane rupture

  • Caspase-1 activity assays

  • GSDMD (gasdermin D) cleavage detection by Western blot

  • IL-1β and IL-18 secretion measurement by ELISA

• Confirmatory Approaches:

  • Rescue experiments with different NR5A2 isoforms to determine isoform-specific functions

  • Pharmacological inhibition of pyroptosis pathways in NR5A2-deficient models

  • In vivo imaging of pyroptosis in hepatocyte-specific knockout mice

The research indicates that NR5A2 deficiency induces pyroptosis, with complete knockout being lethal in some contexts while haploid expression allows for cell survival with a detectable phenotype .

How can researchers distinguish between different NR5A2 isoforms in their studies?

Multiple NR5A2 isoforms have been identified across species: 4 human, 3 mouse, and 3 rat isoforms . Distinguishing between these isoforms requires:

• Isoform-Specific Antibodies:

  • Selection of antibodies targeting unique epitopes in specific isoforms

  • Verification of specificity using recombinant isoform proteins

• RNA Detection Methods:

  • RT-PCR with primers spanning unique exon junctions

  • RNA-seq analysis with appropriate bioinformatic pipelines for isoform quantification

• Expression Vector Systems:

  • Construction of isoform-specific expression vectors for rescue experiments

  • Tagged isoform constructs for subcellular localization studies

• Functional Analysis:

  • Isoform-specific knockdown using targeted siRNAs

  • Differential binding analysis using ChIP-seq with isoform-specific antibodies

Researchers should conduct protein sequence alignment of the different isoforms to identify conserved versus variable regions, which can guide experimental design and interpretation .

What are common issues with NR5A2 detection in Western blot applications and how can they be resolved?

Western blot detection of NR5A2 can present several challenges:

• Low Signal Intensity:

  • Increase antibody concentration (optimal dilutions should be determined empirically)

  • Enhance protein loading (30-50μg total protein recommended)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use enhanced chemiluminescence (ECL) detection systems

• Multiple Bands:

  • Multiple isoforms of NR5A2 exist (expected MW ~55 kDa)

  • Post-translational modifications may alter migration pattern

  • Confirm specificity with knockout/knockdown controls

  • Consider using gradient gels for better resolution

• High Background:

  • Increase blocking time and concentration (5% non-fat milk or BSA)

  • Increase washing duration and buffer volume

  • Reduce secondary antibody concentration

  • Use freshly prepared buffers and reagents

• Tissue-Specific Considerations:

  • Liver samples may require special detergent combinations to solubilize nuclear receptors

  • Brain tissues may benefit from phosphatase inhibitors to preserve modification states

  • Pancreatic samples require robust protease inhibition due to high endogenous protease activity

How can researchers effectively study NR5A2 in complex disease models?

Studying NR5A2 in disease contexts presents unique challenges:

• Inflammation Models:

  • Use a combination of NR5A2 antibodies and inflammatory markers (AP-1 family proteins, cytokines)

  • Consider timing carefully, as NR5A2 relocation to inflammatory gene promoters may be transient

  • Use genetic models (Nr5a2+/− mice) that display pre-inflammatory phenotypes

• Cancer Research Applications:

  • Assess NR5A2 expression patterns in tumor vs. normal tissue

  • Study cooperation between NR5A2 haploinsufficiency, oncogene activation (e.g., mutant KRas), and inflammation

  • Validate with patient samples where NR5A2 expression is altered

• Metabolic Disease Models:

  • Examine NR5A2 binding to metabolic gene promoters

  • Study interactions with other nuclear receptors involved in metabolism

  • Assess NR5A2-dependent metabolite profiles using metabolomics approaches

• Neurodegenerative Conditions:

  • Leverage NR5A2's role in neuronal differentiation

  • Examine relationships between NR5A2 expression and neuronal health

  • Consider both cell-autonomous and non-cell-autonomous effects

In all cases, researchers should employ multiple complementary techniques (immunostaining, Western blot, qPCR, ChIP) for comprehensive analysis of NR5A2 function in disease states.

How might single-cell approaches enhance our understanding of NR5A2 function?

Single-cell technologies offer new insights into NR5A2 biology:

• scRNA-seq Applications:

  • Identify cell populations with differential NR5A2 expression

  • Map NR5A2 expression changes during differentiation trajectories

  • Discover cell-type-specific NR5A2 target genes

• Single-cell Protein Analysis:

  • CyTOF with NR5A2 antibodies can reveal protein expression in heterogeneous tissues

  • Single-cell Western blot for quantitative assessment of NR5A2 in rare populations

• Spatial Transcriptomics:

  • Correlate NR5A2 expression with spatial location in tissues

  • Identify microenvironmental factors influencing NR5A2 activity

• Integrated Multi-omics:

  • Combine single-cell techniques to link NR5A2 expression with chromatin accessibility and downstream effects

These approaches could be particularly valuable for understanding NR5A2's diverse roles across different cell types within the same tissue.

What considerations are important when studying the interplay between NR5A2 and other nuclear receptors?

NR5A2 functions within a complex network of nuclear receptors:

• Co-Immunoprecipitation Strategies:

  • Use NR5A2 antibodies to pull down interaction partners

  • Employ appropriate detergent conditions to preserve nuclear receptor interactions

  • Consider crosslinking approaches for transient interactions

• Sequential ChIP (Re-ChIP):

  • Determine co-occupancy of NR5A2 with other factors at shared genomic loci

  • Optimize antibody combinations and elution conditions

• Proximity Ligation Assays (PLA):

  • Visualize NR5A2 interactions with other factors in situ

  • Quantify interaction frequencies in different cellular compartments

• Competition Assays:

  • Assess competition or cooperation between NR5A2 and other nuclear receptors at shared response elements

  • Study changes in binding patterns under different physiological conditions

Research indicates important functional interactions between NR5A2 and co-repressors like Nr0b2 that modulate its activity on target genes .